Blog

March 17, 2026

Bar chart titled The Coffee Can Portfolio showing yearly values FY20–FY25: 28, 26, 22, 18, 14, with FY25 value 11 in a green bar highlight

The Coffee Can Portfolio: Why Doing Nothing Can Make You Rich

MGMANISH GOEL PMS☰ HomePast PerformanceServicesMedia & PressBlogsAwards WhatsApp · 7380122211 VALUE INVESTING · BLOG The Coffee Can Portfolio: Why Doing Nothing Can Make You Rich ← […]

March 16, 2026

Hero section: article title about Rupee until ₹93/$; subtitle in italics; includes a horizontal bar chart showing FY20–FY25 values, with the final bar highlighted in green (11 in FY25).

Rupee at ₹93/$ — Why This Is a Golden Opportunity for Pharma & Biotech Investors

The Indian Rupee has depreciated to ~93 per US Dollar. While headlines scream doom, smart investors see this as a powerful tailwind for India's $30B+ pharma export engine. India is the Pharmacy of the World — and a weaker rupee makes it even more competitive. Here's why pharma & biotech stocks are the biggest beneficiaries.

March 16, 2026

Hero header with the title 'Economic Moats' and green subtitle on a dark blue background; a two-by-two color block grid labeled Trader (gray), COMPUNDER (green), Drift (light gray), Speculator (orange); footer credit text.

Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy

MGMANISH GOEL PMS☰ HomePast PerformanceServicesMedia & PressBlogsAwards WhatsApp · 7380122211 VALUE INVESTING · BLOG Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy ← […]

March 15, 2026

Hero title: How Titan Biotech Turned ₹1 Lakh with a subtitle about audited FY25 numbers and shares growth (illustrative article header).

How Titan Biotech Turned ₹1 Lakh into ₹50 Lakh — A Value Investing Case Study

Learn how Titan Biotech (BSE:524717) turned ₹1 Lakh into ₹50 Lakh — a real 50x multibagger case study with a 7-step value investing framework by Manish Goel, SEBI Registered Research Analyst.

+91-7380122211